~~<i id='A94F94B3EA'><strike id='A94F94B3EA'><tt id='A94F94B3EA'><pre id='A94F94B3EA'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：hotspot 2025-10-02 10:48:32 - browse：7186

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Study fuels hope CAR

leisure time

focus

entertainment

focus

AdobeAdrugdevelopedbythebiotechfirmBridgeBiototreatanincreasinglycommonheartconditionsucceededinitsm

WSS

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

CDC advisory group OKs chikungunya vaccine

Ohio train derailment: Experts on toxic chemical risks

15 die by electrocution after transformer explodes in northern India

Readout Newsletter: Beam, Prozac, "TechBio" and more

Cholera vaccine supplies dangerously low, outbreaks surging

explore

hotspot

leisure time

Moonlake's readout produced a cash windfall. Risks remain

DeSantis says Trump could've 'come out more forcefully' during Jan. 6

ChatGPT in medicine: STAT answers readers' burning questions

Redefining sustainability for the pharmaceutical industry

Tori Bowie and the unacceptable rates of Black maternal death

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

ChatGPT in medicine: STAT answers readers' burning questions

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

Continuity nursing helped my family in our darkest PICU moments

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

focus

Elisabeth Bik tackles the widespread issue of research misconduct

What we know about the American soldier detained in North Korea

Redefining sustainability for the pharmaceutical industry

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Flagship, Pfizer team up in deal worth up to $7 billion

Elisabeth Bik tackles the widespread issue of research misconduct

focus

focus

entertainment

focus